ArticleScientific reports2024

ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC.

Caterina De Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.